Alzheimer's disease (AD) is a progressive, multifactorial, and unremitting neurodegenerative
disease characterized by memory loss, personality changes, and cognitive impairment. It …

Alzheimer's disease (AD) is a highly prevalent neurodegenerative condition that has
devastating effects on individuals, often resulting in dementia. AD is primarily defined by the …

Alzheimer's disease (AD) is the most common form of dementia. It increases the risk of other
serious diseases and causes a huge impact on individuals, families, and socioeconomics …

Before the controversial approval of humanized monoclonal antibody lecanemab, which
binds to the soluble amyloid‐β protofibrils, all the treatments available earlier, for …

Currently, one of the most significant and rapidly growing unmet medical challenges is the
treatment of neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's …

Highlights•According to in-vitro and in-silico investigations, the phytochemicals discussed in
this review show anti-amyloid potential.•Some phytochemicals have blood brain barrier …

Neurodegenerative diseases are a group of disorders characterized by the progressive
degeneration of neurons in the central or peripheral nervous system. Currently, there is no …

Mesenchymal stem cells (MSCs) have gained attention as a promising therapeutic approach
in both preclinical and clinical osteoarthritis (OA) settings. Various joint cell types, such as …

Alzheimer's disease (AD) is a complex neurological disorder and multiple pathways are
associated with its pathology. Currently available single-targeting drugs are found to be …

Background Millions of people around the globe are affected by Alzheimer's disease (AD).
This crippling condition has no treatment despite intensive studies. Some phytocompounds …